Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intervention NR Cancer occurrence Chinese herbal medicines for benign thyroid nodules in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life Chinese herbal medicines for benign thyroid nodules in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Pressure symptoms/cosmetic complaints Chinese herbal medicines for benign thyroid nodules in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Nodule volume reduction ≥ 50% Chinese herbal medicines for benign thyroid nodules in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Socioeconomic effects Chinese herbal medicines for benign thyroid nodules in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Primary: Child Intellectual development (attainment of educational goals) · children younger than five years of age Centre‐based day care for children younger than five years of age in low‐ and middle‐income countries (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Secondary: Child behaviour · children younger than five years of age Centre‐based day care for children younger than five years of age in low‐ and middle‐income countries (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Secondary: Disrupted child attachment · children younger than five years of age Centre‐based day care for children younger than five years of age in low‐ and middle‐income countries (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Secondary: Paid parental employment · children younger than five years of age Centre‐based day care for children younger than five years of age in low‐ and middle‐income countries (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Severe allergic reaction · persons with severe haemophilia A and factor inhibitory antibodies Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Nephrotic symdrome · persons with severe haemophilia A and factor inhibitory antibodies Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B (2014) · Cochrane | no estimate extracted | NR | No studies |
Tricyclic antidepressants vs placebo Acceptability (all‐cause drop‐outs) · somatoform disorders in adults Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Natural products vs placebo Functional disability and quality of life (post‐treatment score on self report scales) · somatoform disorders in adults Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Tricyclic antidepressants vs another medication Functional disability and quality of life · somatoform disorders in adults Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Tricyclic antidepressants vs placebo Anxiety (post‐treatment score on self report and clinician‐rated scales) · somatoform disorders in adults Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Antidepressants vs a combination of medications Adverse effects (drop‐outs due to adverse effects) · somatoform disorders in adults Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Antidepressants vs a combination of medications Treatment response (post‐treatment score on self report and clinician‐rated scales) · somatoform disorders in adults Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Antidepressants vs a combination of medications Functional disability and quality of life · somatoform disorders in adults Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Tricyclic antidepressants vs placebo Depression (post‐treatment score on self report and clinician‐rated scales) · somatoform disorders in adults Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Tricyclic antidepressants vs placebo Adverse effects (drop‐outs due to adverse effects) · somatoform disorders in adults Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Tricyclic antidepressants vs placebo Treatment response (post‐treatment score on self report and clinician‐rated scales) · somatoform disorders in adults Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Tricyclic antidepressants vs placebo Functional disability and quality of life (post‐treatment score on self report and clinician‐rated scales) · somatoform disorders in adults Pharmacological interventions for somatoform disorders in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Alcohol ban vs no ban Delayed age of initiation of alcohol use ‐ not reported · General population Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents (2014) · Cochrane | no estimate extracted | NR | No studies |
Alcohol ban vs no ban Reduction in alcohol‐related injuries or accidents ‐ not reported · General population Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents (2014) · Cochrane | no estimate extracted | NR | No studies |
Alcohol ban vs no ban Reduction in individual spending on alcohol ‐ not reported · General population Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents (2014) · Cochrane | no estimate extracted | NR | No studies |
Alcohol ban vs no ban Loss of revenue from alcohol industry ‐ not reported · General population Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents (2014) · Cochrane | no estimate extracted | NR | No studies |
Alcohol ban vs no ban Loss of advertising revenue ‐ not reported · General population Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents (2014) · Cochrane | no estimate extracted | NR | No studies |
Non‐alcohol commercials vs alcohol commercials Delayed age of initiation of alcohol use ‐ not measured · General population Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents (2014) · Cochrane | no estimate extracted | NR | No studies |
Non‐alcohol commercials vs alcohol commercials Reduction in rate of reported risk behaviour ‐ not measured · General population Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents (2014) · Cochrane | no estimate extracted | NR | No studies |
Non‐alcohol commercials vs alcohol commercials Reduction in alcohol‐related injuries or accidents ‐ not measured · General population Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents (2014) · Cochrane | no estimate extracted | NR | No studies |
Non‐alcohol commercials vs alcohol commercials Reduction in individual spending on alcohol ‐ not measured · General population Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents (2014) · Cochrane | no estimate extracted | NR | No studies |
Non‐alcohol commercials vs alcohol commercials Loss of revenue from alcohol industry ‐ not measured · General population Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents (2014) · Cochrane | no estimate extracted | NR | No studies |
Non‐alcohol commercials vs alcohol commercials Loss of advertising revenue ‐ not measured · General population Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents (2014) · Cochrane | no estimate extracted | NR | No studies |
Alcohol ban vs no ban Reduction in rate of reported risk behaviour ‐ not reported · General population Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · participants with asthma Vitamins C and E for asthma and exercise‐induced bronchoconstriction (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Asthma exacerbation as defined by hospital admission or treatment with a course of oral corticosteroids · participants with asthma Vitamins C and E for asthma and exercise‐induced bronchoconstriction (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · participants with exercise‐induced asthma Vitamins C and E for asthma and exercise‐induced bronchoconstriction (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Asthma exacerbation as defined by hospital admission or treatment with a course of oral corticosteroids · participants with exercise‐induced asthma Vitamins C and E for asthma and exercise‐induced bronchoconstriction (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events · participants with exercise‐induced asthma Vitamins C and E for asthma and exercise‐induced bronchoconstriction (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR At least 50% reduction in pain or equivalent · neuropathic pain (5 studies in painful diabetic neuropathy and polyneuropathy) Imipramine for neuropathic pain in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR "Moderate" benefit At least 30% reduction in pain · neuropathic pain (5 studies in painful diabetic neuropathy and polyneuropathy) Imipramine for neuropathic pain in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Proportion below 30/100 mm on VAS · neuropathic pain (5 studies in painful diabetic neuropathy and polyneuropathy) Imipramine for neuropathic pain in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Azapirone vs placebo Rate of 'response' · adults with panic disorder Azapirones versus placebo for panic disorder in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Proportion below 30/100 mm on VAS · neuropathic pain (6 studies in central neuropathic pain due to multiple sclerosis, spinal cord injury, polyneuropathy,… Levetiracetam for neuropathic pain in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Patient Global Impression of Change much or very much improved · adults with peripheral neuropathic pain conditions Topical lidocaine for neuropathic pain in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR At least 50% reduction in pain · adults with neuropathic pain (3 studies in painful diabetic neuropathy and postherpetic neuralgia) Desipramine for neuropathic pain in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR At least 30% reduction in pain · adults with neuropathic pain (3 studies in painful diabetic neuropathy and postherpetic neuralgia) Desipramine for neuropathic pain in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Proportion below 30/100 mm on VAS · adults with neuropathic pain (3 studies in painful diabetic neuropathy and postherpetic neuralgia) Desipramine for neuropathic pain in adults (2014) · Cochrane | no estimate extracted | NR | No studies |
Laser photocoagulation vs control Quality of life · people with diabetic retinopathy Laser photocoagulation for proliferative diabetic retinopathy (2014) · Cochrane | no estimate extracted | NR | No studies |
Laser photocoagulation vs control Pain · people with diabetic retinopathy Laser photocoagulation for proliferative diabetic retinopathy (2014) · Cochrane | no estimate extracted | NR | No studies |